OUE Healthcare Limited (5WA) Fair Value & Analysis
Healthcare · SG · Market cap 173M SGD
Fair value as of: Jul 4, 2026
From 15 valuation models · updated today
Share price +14.7% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.0230 SGD – 0.0440 SGD · fair‑value band 0.0589 SGD – 0.1096 SGD · the 0.0390 SGD price screens below the 0.0862 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
OUE Healthcare Limited (5WA) currently trades at 0.0390 SGD, while our model-based Fair Value estimate is 0.0862 SGD — implying the stock looks roughly 121.0% undervalued today. We read business quality at 63/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, OUE Healthcare Limited generated revenue of 152M SGD at a net margin of -11.1%. Revenue grew 2.5% year over year. It earns a return on equity of 1.2%. Net debt stands at 465M SGD. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
OUE Healthcare Limited, an investment holding company, owns, operates, and invests in healthcare businesses in Singapore, China, Myanmar, Indonesia, and Japan. It operates through Healthcare Operations, Healthcare Assets, Properties Under Development, and Investments segments. The company is involved in the operation of hospitals and clinics; supply of medical equipment and pharmaceutical products; and rental of investment properties and owned assets. It also engages in the development of medical facilities, healthcare-related assets, and integrated mixed-used projects; and investment in real estate investment trusts and properties. The company was formerly known as OUE Lippo Healthcare Limited and changed its name to OUE Healthcare Limited in April 2023. The company was founded in 2010 and is headquartered in Singapore. OUE Healthcare Limited is a subsidiary of OUE Limited.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
OUE Healthcare Limited reported revenue of 152M SGD in FY2025 versus 19.7M SGD in FY2021, a compound +66.8%/yr. Reported net income was −16.9M SGD in FY2025.
Is 5WA fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is OUE Healthcare Limited (5WA) undervalued?
What is the fair value of 5WA?
What is the quality score of 5WA?
What is the revenue of OUE Healthcare Limited (5WA)?
What is the net profit margin of 5WA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.